相关实验视频
Updated: Jun 8, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
慢性自发性疹的预后与对奥马利祖马布的不充分反应
Haruka Watanabe1, Shunsuke Takahagi1,2, Koremasa Hayama3
1Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
International journal of dermatology
|November 3, 2024
概括
超过一半的慢性自发性疹 (CSU) 患者在12个月后表现出良好的预后,尽管最初对奥马利祖马布 (OMA) 的反应不足. 某些临床因素和治疗方法影响了这些结果.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 临床医学 临床医学
背景情况:
- 慢性自发性疹 (CSU) 通常对奥马利祖马布 (OMA) 有很好的反应.
- 了解OMA反应不足的患者的预后和治疗策略至关重要.
研究的目的:
- 为了调查CSU患者的12个月预后,他们对三次OMA注射有不充分的反应.
- 确定有利预后的预测因素,并评估干预措施.
主要方法:
- 在48名CSU患者的多中心追溯分析中.
- 评估治疗干预措施 (OMA延续,皮质类固醇,免疫抑制剂) 和12个月后的预后结果.
- 对临床变量进行分析,包括CSU持续时间,血管,IgE,乙酸蛋白和UCT得分.
主要成果:
- 在48名患者中,28名患者在12个月内实现了良好的预后.
- 有利的预后因素包括更短的CSU持续时间,血管的存在,特定的IgE和乙氨基基基水平以及UCT得分.
- 免疫抑制剂与良好的预后相关,而全身性皮质类固醇与不良的预后相关.
结论:
- 超过一半的CSU患者的OMA反应不足经历了12个月后的良好预后.
- 临床变量和特定的治疗剂与CSU管理中的预后结果有关.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Hypersensitivities
524
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
524
Allergic Reactions
27.2K
Overview
27.2K
Antiasthma Drugs: Leukotriene Modifiers
246
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
246
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812

